SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044761
Filing Date
2018-08-14
Accepted
2018-08-14 17:24:06
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499807_10q.htm 10-Q 400193
2 EXHIBIT 31.1 tv499807_ex31-1.htm EX-31.1 8527
3 EXHIBIT 32.1 tv499807_ex32-1.htm EX-32.1 4153
  Complete submission text file 0001144204-18-044761.txt   7272530

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT imnp-20180630.xml EX-101.INS 2275420
5 XBRL TAXONOMY EXTENSION SCHEMA imnp-20180630.xsd EX-101.SCH 57962
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imnp-20180630_cal.xml EX-101.CAL 42785
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imnp-20180630_def.xml EX-101.DEF 397337
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE imnp-20180630_lab.xml EX-101.LAB 388252
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imnp-20180630_pre.xml EX-101.PRE 420801
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36602 | Film No.: 181018965
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1